Skip to main content
Equibles
MESO logo

MESO · Mesoblast Ltd

Track MESO — free

Use MESO with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about MESO

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$17.40 -0.78 (-4.29%)
Rebalance outlook locked
Market Cap
$2.36B
Shares
129.70M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$18.18 Open$17.82 Day$17.38–18.33 52W close$12.88–20.96 Avg vol 30d213K Short int3.0M · 2.3% float · 18.3d Short vol43% Last earningsDec 31, 2025 DataJan 2024–Aug 2026

Raw chart and full-history price indicators begin at the captured split on Jan 10, 2024; bars on opposite sides are not compared.

Up next

FQ1-27 quarter ends
~Sep 30, 2026 Est

Equibles Rating

blended score · not investment advice
Overall
Buy
SellHoldBuy
Technical Buy Momentum Strong Sentiment Bullish Fundamentals Limited Quant / Vol High
Market backdrop VIX 14.5 · calm Equity put/call 0.39
Technical
price trend
Buy
50 / 200-day cross No cross
Price vs 200-day avg +13%
above
Price vs 50-day avg +16%
above
RSI (14) 63
neutral
MACD trend Positive
52-week position 66%
mid-range
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Strong
1-month return +25%
trailing
6-month return +15%
trailing
YTD return +1%
this year
Relative strength 0%
vs S&P · 6-mo
Sentiment
smart money
Bullish
Trend (MA cross) No cross
50d $16 › 200d $16 — 200d above 50d
Institutional flow Accumulating
+4% holders QoQ · +9 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
2.32% of float · ▼ -5.1% MoM · 18.3 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
72 holders — mid 3-yr range
Squeeze score 61
elevated · 0–100
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
High
Volatility 58%
annualized · 1-yr
Max drawdown −37%
past year
ATR 4.0%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Prior guidance period ended · from the Earnings Call filed Dec 31, 2025
Ryoncil net revenues · full year 2026 $110M – $120M

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Buy
0 · 4 · 3
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+13% Bullish
Price vs 50-day avg
+16% Bullish
RSI (14)
63 Neutral
MACD trend
Positive Bullish
52-week position
66% Neutral
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross) No cross
50d $16 › 200d $16 — 200d above 50d
Institutional flow Accumulating
+4% holders QoQ · +9 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
2.32% of float · ▼ -5.1% MoM · 18.3 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
72 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $13 Now $18 · 66% Range high $21
vs 200-day avg +13% vs 50-day avg +16%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Biotechnology — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
MESO
Mesoblast Ltd
this stock
$2.36B +0.8% — — 2.3%
VRTX
Vertex Pharmaceuticals Inc / Ma
 $138.72B +20.8% +46.2% 31.9 1.6%
REGN
Regeneron Pharmaceuticals, Inc.
 $81.27B +4.6% +20.8% 19.6 2.3%
ARGX
Argenx SE
 $65.12B +25.9% — — 1.9%
CSLLY
Csl Ltd
 $59.92B — — — 0.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
72
% held
4.9%
Net QoQ
+1.6M sh
Top holder
JANE STREET GROUP, LLC
Held Float
View
Held by Funds
Fund positions
9
View
Short & Settlement
Short Interest Falling
Shares short
3.0M
Days to cover
18.3d
Change
-162.4K sh
View
Short Volume
Short vol %
43%
As of
Aug 27, 2026
Short Total
View
Fails to Deliver
FTD shares
795
Value
$11.6K
As of
Jul 31, 2026
View
Off-Exchange
Off-exchange %
41.7%
Week of
Jul 20, 2026
Off-exch Lit
View
Filings
SEC Filings
Latest
6-K
Filed
Aug 27, 2026
This year
38
View
Exempt Offerings
Offering
$6.5M
Filed
May 26, 2020
View
Earnings & Events
Earnings Calls
Last call
Dec 31, 2025
View
Investor Relations
Latest news
MSB Annual Financial Results and…
Published
Aug 26, 2026
View

Performance

Raw-price comparisons begin at the captured split on Jan 10, 2024; windows that need an earlier baseline remain unavailable.

5D 20D 120D MTD YTD
MESO +4.3% +25.0% +14.7% +28.3% +0.8%
SPY +1.1% +4.0% +14.7% +3.2% +13.1%
vs SPY +3.2% +21.0% +0.0% +25.1% -12.3%
Key facts CIK 1345099 CUSIP 590717401 13F (30d) 60 filings 60 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)